Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-27 @ 9:21 AM
Study NCT ID:
NCT00001934
Status:
COMPLETED
Last Update Posted:
2011-08-05
First Post:
1999-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zenapax to Treat Multiple Sclerosis
Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-09
Start Date Type:
None
Primary Completion Date:
2005-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09
Completion Date Type:
ACTUAL
First Submit Date:
1999-11-03
First Submit QC Date:
None
Study First Post Date:
1999-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-08-04
Last Update Post Date:
2011-08-05
Last Update Post Date Type:
ESTIMATED